After a Rally, Biotech ETF Faces Resistance
June 11, 2014 at 15:00 PM EDT
In frustrating news for some short sellers, the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB) is up 7.5% in the past month and nearly 15% from its April trough. Now the largest biotech ETF by assets is facing its first legitimate tussle with a key resistance level following its bounce from its...